Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

706
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
706
Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

558
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
558
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

572
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
572
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

976
Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
976
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

422
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
422
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

592
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
592

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cardiorespiratory Fitness and Age-Related Decline in Kidney Function among Individuals with Preserved Kidney Health: The Aging Kidney Study.

Medicine and science in sports and exercise·2026
Same author

Renal tubular calcium phosphate microcrystallopathy and age-related kidney function decline: The Aging Kidney Study.

Clinical kidney journal·2026
Same author

Calciprotein particles in cats with naturally occurring chronic kidney disease.

Journal of veterinary internal medicine·2026
Same author

Dysregulated Klotho and FGF23 signalling aggravates vascular remodelling in age-related pulmonary hypertension.

Cardiovascular research·2026
Same author

Bone mineral loss damages renal tubules in mice.

Communications biology·2026
Same author

Circulating fibroblast growth factor 23 and physical performance in middle-aged and older adults with normal kidney function.

Scientific reports·2025

Related Experiment Video

Updated: May 6, 2026

Validation of Therapeutic Agent Conjugation to Polyvinyl Alcohol-Coated Medical Devices
06:34

Validation of Therapeutic Agent Conjugation to Polyvinyl Alcohol-Coated Medical Devices

Published on: November 29, 2024

746

Calciprotein particles: is it time for therapeutic intervention?

Makoto Kuro-O1

  • 1Division of Mineral Metabolism, Center for Molecular Medicine, Jichi Medical University, Yakushiji, Shimotsuke, Tochigi, Japan.

Current Opinion in Nephrology and Hypertension
|May 5, 2026
PubMed
Summary

Calciprotein particles (CPPs) are active in chronic kidney disease (CKD) complications. Targeting CPPs may offer a new therapeutic strategy for CKD patients, but further trials are needed to confirm clinical benefit.

Keywords:
T50calciprotein particlesinflammationvascular calcification

More Related Videos

Detection and Quantification of Calcitonin Gene-Related Peptide CGRP in Human Plasma Using a Modified Enzyme-Linked Immunosorbent Assay
07:14

Detection and Quantification of Calcitonin Gene-Related Peptide CGRP in Human Plasma Using a Modified Enzyme-Linked Immunosorbent Assay

Published on: June 16, 2023

3.6K
Investigating Aortic Valve Calcification via Isolation and Culture of T Lymphocytes using Feeder Cells from Irradiated Buffy Coat
04:30

Investigating Aortic Valve Calcification via Isolation and Culture of T Lymphocytes using Feeder Cells from Irradiated Buffy Coat

Published on: February 4, 2021

3.0K

Related Experiment Videos

Last Updated: May 6, 2026

Validation of Therapeutic Agent Conjugation to Polyvinyl Alcohol-Coated Medical Devices
06:34

Validation of Therapeutic Agent Conjugation to Polyvinyl Alcohol-Coated Medical Devices

Published on: November 29, 2024

746
Detection and Quantification of Calcitonin Gene-Related Peptide CGRP in Human Plasma Using a Modified Enzyme-Linked Immunosorbent Assay
07:14

Detection and Quantification of Calcitonin Gene-Related Peptide CGRP in Human Plasma Using a Modified Enzyme-Linked Immunosorbent Assay

Published on: June 16, 2023

3.6K
Investigating Aortic Valve Calcification via Isolation and Culture of T Lymphocytes using Feeder Cells from Irradiated Buffy Coat
04:30

Investigating Aortic Valve Calcification via Isolation and Culture of T Lymphocytes using Feeder Cells from Irradiated Buffy Coat

Published on: February 4, 2021

3.0K

Area of Science:

  • Biochemistry
  • Nephrology
  • Cardiovascular Medicine

Background:

  • Calciprotein particles (CPPs) are nanoparticles of calcium phosphate and proteins, primarily fetuin-A.
  • CPPs were initially considered a defense against ectopic calcification but are now linked to chronic kidney disease (CKD).

Purpose of the Study:

  • To review the role of CPPs in CKD pathogenesis and complications.
  • To explore CPPs as potential therapeutic targets in CKD.

Main Methods:

  • Review of experimental and clinical studies on CPPs in CKD.
  • Analysis of CPPs' cellular effects, clinical associations, and interventional data.

Main Results:

  • CPP uptake induces cellular dysfunction, oxidative stress, and inflammasome activation.
  • Elevated CPP levels and T50 correlate with vascular calcification, cardiovascular events, and mortality in CKD.
  • Modulating CPPs affects vascular and inflammatory markers in vivo.

Conclusions:

  • CPPs are implicated as pathogenic mediators in CKD complications.
  • Targeting CPPs presents a promising therapeutic avenue for CKD.
  • Clinical efficacy of CPP-targeted therapies requires further investigation in ongoing trials.